Literature DB >> 17426198

Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension.

Marcin Kurzyna1, Marek Dabrowski, Dariusz Bielecki, Anna Fijalkowska, Piotr Pruszczyk, Grzegorz Opolski, Janusz Burakowski, Michal Florczyk, Witold Z Tomkowski, Liliana Wawrzynska, Monika Szturmowicz, Adam Torbicki.   

Abstract

BACKGROUND: Right ventricular (RV) failure is the main cause of death in patients with pulmonary hypertension (PH). Balloon atrial septostomy (BAS) is believed to relieve symptoms of PH by increasing systemic flow and reducing RV preload.
METHODS: Fourteen BAS procedures were performed in 11 patients (5 men and 6 women; mean [+/- SD] age, 33 +/- 12 years) with RV failure in the course of PH that was refractory to conventional treatment. BAS consisted of a puncture of the interatrial septum and subsequent dilatations with balloons of increasing diameter in a step-by-step manner.
RESULTS: After BAS, the mean oxygen saturation of aortic blood decreased (before, 93 +/- 4%; after, 84 +/- 4%; p = 0.001), while mean cardiac index increased (before, 1.54 +/- 0.34 L/min/m(2); after, 1.78 +/- 0.35 L/min/m(2); p = 0.001), resulting in a positive trend for mean systemic oxygen transport (before, 270 +/- 64 mL/min; after, 286 +/- 81 mL/min; p = 0.08). Pulmonary vascular resistance (PVR) slightly increased immediately after the procedure, and this rise inversely correlated with mixed venous blood partial oxygen pressure both before BAS (r = -0.69; p = 0.009) and after BAS (r = -0.64; p = 0.018). Mean functional class improved from 3.2 +/- 0.4 to 2.6 +/- 0.7 (p = 0.03) after 1 month. At follow-up (mean time to follow-up, 8.1 +/- 6.2 months; range, 0.8 to 20.2 months), seven patients died and two underwent lung transplantation. There was no difference in the survival rate compared to that obtained from National Institutes of Health equation. A significant size reduction in the created defect was observed in six patients, requiring repeat BAS procedures in three cases.
CONCLUSIONS: The current BAS technique improves cardiac index and functional class without significant periprocedural complications, except for a transient increase in PVR related to acute desaturation of mixed venous blood. At long-term follow-up, a high incidence of spontaneous decrease in orifice size has been observed.

Entities:  

Mesh:

Year:  2007        PMID: 17426198     DOI: 10.1378/chest.06-1227

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Interatrial shunt for chronic pulmonary hypertension: differential impact of low-flow vs. high-flow shunting.

Authors:  Andreas Zierer; Spencer J Melby; Rochus K Voeller; Marc R Moon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-09       Impact factor: 4.733

2.  Long-term animal model of venovenous extracorporeal membrane oxygenation with atrial septal defect as a bridge to lung transplantation.

Authors:  Daniele Camboni; Alvaro Rojas; Peter Sassalos; David Spurlock; Kelly L Koch; Sarah Menchak; Jennifer Singleton; Erika Boothman; Jonathan W Haft; Robert H Bartlett; Keith E Cook
Journal:  ASAIO J       Date:  2013 Nov-Dec       Impact factor: 2.872

3.  Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction.

Authors:  Alicja Dąbrowska-Kugacka; Dariusz Ciećwierz; Grzegorz Żuk; Marcin Fijałkowski; Antoni Ottowicz; Joanna Kwiatkowska; Ewa Lewicka; Robert Sabiniewicz
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

Review 4.  Current clinical management of pulmonary arterial hypertension.

Authors:  Roham T Zamanian; Kristina T Kudelko; Yon K Sung; Vinicio de Jesus Perez; Juliana Liu; Edda Spiekerkoetter
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 5.  Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies.

Authors:  Alan B Goldberg; Wojciech Mazur; Dinesh K Kalra
Journal:  Cardiovasc Diagn Ther       Date:  2017-08

Review 6.  Treatment of pulmonary arterial hypertension with targeted therapies.

Authors:  Dermot S O'Callaghan; Laurent Savale; David Montani; Xavier Jaïs; Olivier Sitbon; Gérald Simonneau; Marc Humbert
Journal:  Nat Rev Cardiol       Date:  2011-07-19       Impact factor: 32.419

Review 7.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

8.  Consecutive Sessions of Rescue Balloon Atrial Septostomy for an Idiopathic Pulmonary Arterial Hypertension Patient with Refractory Right Heart Failure - Usefulness of Intracardiac Echocardiography Guidance.

Authors:  Yu-Wei Chen; Hung-Chih Pan; Kuo-Yang Wang; Kae-Woei Liang
Journal:  Acta Cardiol Sin       Date:  2017-05       Impact factor: 2.672

9.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

10.  Potts anastomosis for children with idiopathic pulmonary hypertension.

Authors:  Fabien Labombarda; Pascale Maragnes; Peggy Dupont-Chauvet; Alain Serraf
Journal:  Pediatr Cardiol       Date:  2009-07-28       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.